Meet us at TCT 2016

Transcatheter Cardiovascular Therapeutics (TCT) is the world’s foremost educational meeting specializing in interventional cardiovascular medicine. This year, TCT 2016 will be hosted October 29th – November 2nd in Washington D.C. The transcatheter cardiovascular innovation space is ever evolving which makes this conference valuable to the T3 Labs team- but we are particularly excited about TCT…

Grab insights on development paths for spine therapy innovation including preclinical testing in the $15 billion global market. Connect onsite with T3 Labs at NASS 2016.

According to Markets and Markets Research, the global market for spinal implants and devices will top $15 billion by 2020. In North America, the gathering with arguably the greatest ability to influence that market, its innovation and growth is the North American Spine Society (NASS) Annual Meeting. T3 Labs’ Orthopaedic and Spine Program Director Dr.…

Meeting the top needs in preclinical cardiology. Understanding the interaction of next generation bioresorbable platforms with underlying vascular tissue.

How T3 Labs helped Abbott Vascular, Dr. Bill Gogas, Dr. Sandeep Kumar, the core teams of Emory University lead by Dr. Habib Samady, and Georgia Tech lead by Dr. Hanjoong Jo, generate and utilize observations from a very long-term translational study toward the understanding of very late vasomotor responses and gene expression profiles in arteries…

Breakthroughs in preventing and treating GI disorders: what to look forward to at ACG 2016

The American College of Gastroenterology annual conference serves as the premier gastrointestinal event of the year: delivering the latest clinical updates on a wide spectrum of GI disorders. The ACG’s mission is to advance world-class care for patients with gastrointestinal disorders using innovative methods in prevention and treatment. As an industry leading preclinical CRO for…

Gearing up to network with cardiothoracic thought leaders in Barcelona at EACTS 2016!

The European Association for Cardio-Thoracic Surgery (EACTS) is holding their annual meeting from October 1-5 in Barcelona, Spain. T3 Labs was originally founded as a cardiovascular research institute, and boasts a decade long track-record in preclinical cardiovascular studies. “The facilities [at T3 Labs] are top tier. They are designed to make it easy to move…

biologics

A few features of the 2016 Georgia Bio Innovation Summit that have us counting down the days

For more than 14 years, Georgia Bio has presented Georgia’s premier bioscience and medtech conference welcoming more than 600 CEOs, senior executives, scientists and public policy officials from across the nation. If you are an early stage medtech innovator and want to talk about your device’s or product’s path to regulatory approval, including preclinical studies,…

From the back of the napkin through preclinical and commercialization for cardiology interventions

T3 Labs and GCMI always stand ready to help new medical devices and their innovators advance from ‘back of the napkin’ ideas often generated in clinical practice from concept to commercialization and eventually, to cure. Recently T3 Labs’ Deepal Panchal joined Health Connect South Radio Host CW Hall and Dr. Neil Weintraub, MD, Kupperman Eminent…

Bioskills educators & facilities: teaching the next generation of surgeons their craft

Over 2,000 physicians and allied health professionals participate in bioskills training programs at T3 Labs every year. Among them is Dr. Keith Delman, director of the Carlos and Davis Center for Surgical Anatomy and Technique at the Emory University School of Medicine. Board certified by the American Board of Surgery as well, Dr. Delman shared…

Update: State of Medtech Innovation in the Southeast

T3 Labs Training Program Director Kelley Bennett joined SEMDA Executive Director Jason Rupp and GCMI Executive Director Tiffany Wilson on Health Connect South Radio last week. Give a listen to the current state of medtech innovation in the southeast and how T3 Labs supports our vibrant medtech ecosystem. Via our colleagues Jay Schaffer and CW…